181 related articles for article (PubMed ID: 9877212)
1. Pharmacokinetics and pharmacodynamics of a novel estrogen delta8-estrone in postmenopausal women and men.
Bhavnani BR; Cecutti A; Gerulath A
J Steroid Biochem Mol Biol; 1998 Oct; 67(2):119-31. PubMed ID: 9877212
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism.
Bhavnani BR
Proc Soc Exp Biol Med; 1998 Jan; 217(1):6-16. PubMed ID: 9421201
[TBL] [Abstract][Full Text] [Related]
3. Comparison of pharmacokinetics of a conjugated equine estrogen preparation (premarin) and a synthetic mixture of estrogens (C.E.S.) in postmenopausal women.
Bhavnani BR; Nisker JA; Martin J; Aletebi F; Watson L; Milne JK
J Soc Gynecol Investig; 2000; 7(3):175-83. PubMed ID: 10865186
[TBL] [Abstract][Full Text] [Related]
4. Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's.
Bhavnani BR
J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):473-82. PubMed ID: 12943738
[TBL] [Abstract][Full Text] [Related]
5. Estrogen activity and novel tissue selectivity of delta8,9-dehydroestrone sulfate in postmenopausal women.
Baracat E; Haidar M; Lopez FJ; Pickar J; Dey M; Negro-Vilar A
J Clin Endocrinol Metab; 1999 Jun; 84(6):2020-7. PubMed ID: 10372704
[TBL] [Abstract][Full Text] [Related]
6. Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors (ERs) ERalpha and ERbeta.
Bhavnani BR; Tam SP; Lu X
Endocrinology; 2008 Oct; 149(10):4857-70. PubMed ID: 18599548
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of 17 beta-dihydroequilin sulfate and 17 beta-dihydroequilin in normal postmenopausal women.
Bhavnani BR; Cecutti A
J Clin Endocrinol Metab; 1994 Jan; 78(1):197-204. PubMed ID: 8288704
[TBL] [Abstract][Full Text] [Related]
8. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.
Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C
Menopause; 2009; 16(1):30-6. PubMed ID: 18820592
[TBL] [Abstract][Full Text] [Related]
9. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
Zhao L; Brinton RD
BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
[TBL] [Abstract][Full Text] [Related]
10. Steady-state pharmacokinetics of conjugated equine estrogens in healthy, postmenopausal women.
Mayer P; Tse S; Sendi M; Bourg D; Morrison D
J Reprod Med; 2008 Feb; 53(2):97-101. PubMed ID: 18357800
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
Schindler AE; Bolt HM; Zwirner M; Hochlehnert G; Göser R
Arzneimittelforschung; 1982; 32(7):787-91. PubMed ID: 6289846
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of orally administered estradiol valerate. Results of a single-dose cross-over bioequivalence study in postmenopausal women.
Zimmermann H; Koytchev R; Mayer O; Börner A; Mellinger U; Breitbarth H
Arzneimittelforschung; 1998 Sep; 48(9):941-7. PubMed ID: 9793623
[TBL] [Abstract][Full Text] [Related]
13. The metabolism of estrone sulfate in the female rhesus monkey.
Longcope C; Flood C; Tast J
Steroids; 1994 Apr; 59(4):270-3. PubMed ID: 8079382
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of equilin and equilin sulfate in normal postmenopausal women and men.
Bhavnani BR; Woolever CA; Benoit H; Wong T
J Clin Endocrinol Metab; 1983 May; 56(5):1048-56. PubMed ID: 6300173
[TBL] [Abstract][Full Text] [Related]
15. A conjugated equine estrogen with differential effects on uterine weight and plasma cholesterol in the rat.
Washburn SA; Adams MR; Clarkson TB; Adelman SJ
Am J Obstet Gynecol; 1993 Aug; 169(2 Pt 1):251-4; discussion 254-6. PubMed ID: 8395768
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C.
Tamai I; Nozawa T; Koshida M; Nezu J; Sai Y; Tsuji A
Pharm Res; 2001 Sep; 18(9):1262-9. PubMed ID: 11683238
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic comparison between Conpremin (Premarin) and a generic preparation of conjugated estrogens.
Arteaga E; Villaseca P
Climacteric; 1998 Dec; 1(4):284-9. PubMed ID: 11907935
[TBL] [Abstract][Full Text] [Related]
18. Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol.
Price TM; Blauer KL; Hansen M; Stanczyk F; Lobo R; Bates GW
Obstet Gynecol; 1997 Mar; 89(3):340-5. PubMed ID: 9052581
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of 17 beta-dihydroequilin sulfate in normal postmenopausal women under steady state conditions.
Bhavnani BR; Cecutti A; Gerulath A
J Soc Gynecol Investig; 2002; 9(2):102-10. PubMed ID: 12398033
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of a new conjugated oral estrogen, estradiol-3beta-glucoside, with oral micronized 17beta-estradiol in postmenopausal women.
Sweeney AT; Tangpricha V; Weinberg J; Malabanan AO; Chimeh FN; Holick MF
Transl Res; 2006 Oct; 148(4):164-70. PubMed ID: 17002918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
